© Globe Newswire
28.08.2025
ATAI
LISTED
NASDAQ
atai Life Sciences to Participate in September Investor Conferences
News Preview
NEW YORK and AMSTERDAM, Aug. 28, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company on a mission to develop highly effective mental health treatments to transform patient outcomes, today announced that its management is scheduled to participate in upcoming September investo...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
NUTX
LISTED
NASDAQ
Deadline Alert: Nutex Health Inc. (NUTX) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
News Preview
Glancy Prongay & Murray LLP reminds investors of the upcoming October 21, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) securities between August 8, 2024 and August 14, 2025, inclusive (the “Class Per...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ERF
LISTED
EURONEXT
Eurofins Scientific: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF T...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© PR Newswire
28.08.2025
CAMX
LISTED
STO
Camurus announces approval of Oczyesa® for the treatment of acromegaly in the UK
News Preview
LUND, Sweden, Aug. 28, 2025 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Oczyesa®, octreotide subcutaneous depot, marketing authorization for the maintenance treatment in adult patients with acromegaly who have responded to and tolerated treatment wi...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
28.08.2025
AGEN
LISTED
NASDAQ
FDA Tightens Survival Standards as Cancer Drug Pipeline Hits $866B Market Milestone
News Preview
USA News Group News Commentary
Issued on behalf of Oncolytics Biotech Inc.
VANCOUVER, BC, Aug. 28, 2025 /CNW/ -- Federal budget cuts have put pressure on cancer research efforts in the United States, but private investment is helping to fill the gap, with oncology ventures securing hundreds of millions in funding so far in 2025. The Senate's rece...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
INTEG B
LISTED
STO
Integrum AB: Invitation to the First Quarter 2025/26 Results Presentation
News Preview
MÖLNDAL, Sweden, Aug. 28, 2025 /PRNewswire/ -- Integrum (publ) (Nasdaq First North Growth Market: INTEG B) will host a webcast presentation of its first quarter 2025/26 results on September 1, 2025 at 10:00 CET.
Integrum's CEO Martin Hillsten will present the report together with CFO Jörgen Svanström in a webcast. The presentation will be held i...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ZEAL
LISTED
CPH
Zealand Pharma to participate in upcoming investor conferences in September 2025
News Preview
Press release – No. 12 / 2025...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ZLAB
LISTED
NASDAQ
Zai Lab Announces Participation in Investor Conferences in September 2025
News Preview
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the Company’s senior management team will participate in the following investor conferences in September 2025:
Cantor Global Healthcare Conference
Presentation: Thursday, September 4, 2025, 10:20 a.m. ET
Location: New York, NY
Morgan Stanley 23rd Annual Global Healthcar...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
DFTX
LISTED
NASDAQ
MindMed to Participate in September Investor Conferences
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Company’s management team will participate in the following investor conferences:
Cantor Global Healthcare Conference 2...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
NSIS B
LISTED
CPH
Amendment: Trading by management and close relations of management
News Preview
Please read the announcement in PDF...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
NSIS B
LISTED
CPH
Trading by management and close relations of management
News Preview
Please read the announcement in PDF...
Themefolio
Profiler
Peergroup
© EQS Newswire
28.08.2025
GXI
LISTED
XETR
Gerresheimer expands financial flexibility to implement growth strategy
News Preview
Gerresheimer expands financial flexibility to implement growth strategy
Loans of EUR 200 million to repay part of the bridge financing for the acquisition of Bormioli Pharma ahead of schedule
Expansion of flexibility in key contractual terms
Duesseldorf, August 28, 2025. Gerresheimer, an innovative system and solution provider and global partner ......
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© EQS Newswire
28.08.2025
GXI
LISTED
XETR
Gerresheimer weitet finanzielle Flexibilität zur Umsetzung der Wachstumsstrategie aus
News Preview
Gerresheimer weitet finanzielle Flexibilität zur Umsetzung der Wachstumsstrategie aus
Darlehen über 200 Mio. EUR zur vorzeitigen Ablösung eines Teils der Brückenfinanzierung für die Akquisition von Bormioli Pharma
Ausweitung der Flexibilität bei wesentlichen Vertragsbedingungen
Düsseldorf, 28. August 2025. Gerresheimer, innovativer System- und Lö......
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
IBAB
LISTED
EURONEXT
IBA reports strong Half Year 2025 results, transforming towards a more profitable business
News Preview
Read the entire half year 2025 results press release here...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ANAB
LISTED
NASDAQ
Anaptys Announces Participation in September Investor Conferences
News Preview
SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief executive officer of Anaptys, and/or other members of its executive leadership team, are scheduled to participate in mu...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
CELC
LISTED
NASDAQ
Celcuity to Initiate NDA Submission of Gedatolisib in PIK3CA Wild-Type Cohort in HR+/HER2- Advanced Breast Cancer Under FDA’s Real-Time Oncology Review Program
News Preview
MINNEAPOLIS, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the U.S. Food and Drug Administration (“FDA”) agreed to accept its New Drug Application (“NDA”) for gedatolisib in HR+/HER2- advanced breast cancer (“ABC”) for...
Themefolio
Profiler
Peergroup
© BusinessWire
27.08.2025
NUTX
LISTED
NASDAQ
Deadline Approaching: Nutex Health Inc. (NUTX) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith
News Preview
Law Offices of Howard G. Smith reminds investors of the upcoming October 21, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) securities between August 8, 2024 and August 14, 2025, inclusive (the “Class Period”).
IF YOU ARE AN INVESTOR...
Themefolio
Profiler
Peergroup
© BusinessWire
27.08.2025
BAYN
LISTED
XETR
Gadoquatrane New Drug Application Accepted for Review by U.S. FDA
News Preview
Bayer today announced that a New Drug Application (NDA) for its investigational contrast agent gadoquatrane has been accepted for review by the U.S. Food and Drug Administration (FDA). The NDA for gadoquatrane has been filed for contrast-enhanced magnetic resonance imaging of the central nervous system (CNS) and other body regions in adults and pe...
Themefolio
Profiler
Peergroup
© BusinessWire
27.08.2025
SLP
LISTED
NASDAQ
Simulations Plus to Participate in Upcoming Investor Conferences
News Preview
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”, “SLP”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced that Shawn O’Connor, Chief Executive Officer, will be participating in the following investor events...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
SKYE
LISTED
NASDAQ
Skye Bioscience to Host Virtual KOL Event and Provide Perspectives on Upcoming CBeyond™ Phase 2a Topline Clinical Data Readout
News Preview
Virtual KOL event will begin at 8:00 AM ET on Thursday, September 4, 2025 Virtual KOL event will begin at 8:00 AM ET on Thursday, September 4, 2025...
Themefolio
Profiler
Peergroup
© Newsfile
27.08.2025
COPN
LISTED
SIX
Cosmo Receives Positive CHMP Opinion for Winlevi(R) for Treatment of Acne in Adults and Adolescents, Following Successful Re-Examination
News Preview
Dublin, Ireland--(Newsfile Corp. - August 27, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-powered healthcare and specialty pharma, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending European approval of...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
AGFB
LISTED
EURONEXT
The Agfa-Gevaert Group in Q2 2025: strong HealthCare IT performance, stable Digital Print & Chemicals performance – further decline in medical film
News Preview
Regulated information August 27, 2025 - 7:45 a.m. CET The Agfa-Gevaert Group in Q2 2025: strong HealthCare IT performance, stable Digital Print & Chemicals performance – further decline in medical film...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
INSP
LISTED
NYSE
Inspire Medical Systems, Inc. Announces Departure of Chief Financial Officer
News Preview
MINNEAPOLIS, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its Chief Financial Officer, Rick Buchholz, will be stepping...
Themefolio
Profiler
Peergroup
© PR Newswire
26.08.2025
BIM
LISTED
EURONEXT
OhioHealth Partners with bioMérieux as Newest Global Antimicrobial Stewardship Center of Excellence
News Preview
OhioHealth is only the 4th to receive the designation in the country, and the first regional healthcare system.
SALT LAKE CITY and COLUMBUS, Ohio, Aug. 26, 2025 /PRNewswire/ -- bioMérieux, a world leader in in vitro diagnostics, is proud to announce Columbus, Ohio, based, not-for-profit healthcare system, OhioHealth and The OhioHealth Microbiolog...
Themefolio
Profiler
Peergroup
© BusinessWire
26.08.2025
NUTX
LISTED
NASDAQ
Law Offices of Frank R. Cruz Encourages Nutex Health Inc. (NUTX) Investors To Inquire About Securities Fraud Class Action
News Preview
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) securities between August 8, 2024 and August 14, 2025, inclusive (the “Class Period”). Nutex investors have until October 21, 2025 to file a lead plaintiff motion....
Themefolio
Profiler
Peergroup
© PR Newswire
26.08.2025
AFX
LISTED
XETR
ZEISS showcases comprehensive workflow for full spectrum of retina care at EURETINA
News Preview
At EURETINA 2025, ZEISS Medical Technology combines its diagnostic, surgical and digital technologies to support healthcare professionals in advancing retinal care:
IMPROVE PATHOLOGY DETECTION: Now CE mark approved, CIRRUS® PathFinderTM AI decision support tool streamlines OCT data review; ICGA for CLARUS® 700 offers FA + ICG simultaneous capture...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
GMAB
LISTED
CPH
Genmab to Participate in a Fireside Chat at the Morgan Stanley 23rd Annual Global Healthcare Conference
News Preview
Media ReleaseCOPENHAGEN, Denmark; August 26, 2025Genmab A/S (Nasdaq: GMAB) announced today that its Chief Executive Officer Jan Van de Winkel and Chief Financial Officer Anthony Pagano will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York City, NY at 7:45 AM EDT (1:45 PM CEST) on September 9,...
Themefolio
Profiler
Peergroup
© EQS Newswire
26.08.2025
VLA
LISTED
EURONEXT
First Berlin Equity Research GmbH: Valneva SE | Rating: Buy
News Preview
Original-Research: Valneva SE - from First Berlin Equity Research GmbH
26.08.2025 / 11:25 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain......
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
TFX
LISTED
NYSE
Teleflex to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
News Preview
WAYNE, Pa., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Management of Teleflex Incorporated (NYSE: TFX) will be presenting at the Morgan Stanley 23rd Annual Global Healthcare Conference at the Sheraton New York Times Square, on Tuesday, September 9, 2025, at 3:20 p.m. (ET)....
Themefolio
Profiler
Peergroup
© PR Newswire
26.08.2025
BIOA B
LISTED
STO
BioArctic and Novartis sign an option, collaboration and license agreement using BrainTransporter™ for an upfront payment of USD 30 million plus additional potential milestones and royalties
News Preview
STOCKHOLM, Aug. 26, 2025 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that the company has entered into an option, collaboration and license agreement with Novartis Pharma AG regarding a potential new treatment combining BioArctic's proprietary BrainTransporter technology with an undisclosed target in neurodegene...
Themefolio
Profiler
Peergroup
© PR Newswire
26.08.2025
BIOA B
LISTED
STO
BioArctic and Novartis sign an option, collaboration and license agreement using BrainTransporter™ for an upfront payment of USD 30 million plus additional potential milestones and royalties
News Preview
STOCKHOLM, Aug. 26, 2025 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that the company has entered into an option, collaboration and license agreement with Novartis Pharma AG regarding a potential new treatment combining BioArctic's proprietary BrainTransporter technology with an undisclosed target in neurodegene...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
BAVA
LISTED
CPH
Publication of statement by the Board of Directors in respect of the takeover offer to the shareholders of Bavarian Nordic from the consortium led by Nordic Capital and Permira
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
BAVA
LISTED
CPH
Publication of offer document in respect of the takeover offer to the shareholders of Bavarian Nordic from the consortium led by Nordic Capital and Permira and lowering of minimum acceptance condition to 75%
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION...
Themefolio
Profiler
Peergroup
© BusinessWire
26.08.2025
NUTX
LISTED
NASDAQ
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Nutex Health Inc. (NUTX) Investors to Inquire About Securities Fraud Class Action
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) securities between August 8, 2024 and August 14, 2025, inclusive (the “Class Pe...
Themefolio
Profiler
Peergroup
© BusinessWire
25.08.2025
NUTX
LISTED
NASDAQ
Law Offices of Howard G. Smith Encourages Nutex Health Inc. (NUTX) Investors To Inquire About Securities Fraud Class Action
News Preview
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) securities between August 8, 2024 and August 14, 2025, inclusive (the “Class Period”). Nutex investors have until October 21, 2025 to file a lead plaintiff motion.
IF...
Themefolio
Profiler
Peergroup
© BusinessWire
25.08.2025
NUTX
LISTED
NASDAQ
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nutex Health
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) and reminds investors of the October 21, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi &...
Themefolio
Profiler
Peergroup
© BusinessWire
25.08.2025
NUTX
LISTED
NASDAQ
NUTX Investors Have Opportunity to Lead Nutex Health Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Nutex Health Inc. (“Nutex” or “the Company”) (NASDAQ: NUTX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Invest...
Themefolio
Profiler
Peergroup
© BusinessWire
25.08.2025
NUTX
LISTED
NASDAQ
Rosen Law Firm Urges Nutex Health Inc. (NASDAQ: NUTX) Stockholders to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025. Nutex describes itself as a “physician-led, healthcare services and operations company.”
For more information, submit a form, em...
Themefolio
Profiler
Peergroup
© BusinessWire
25.08.2025
NUTX
LISTED
NASDAQ
NUTEX HEALTH SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Nutex Health Inc. - NUTX
News Preview
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 21, 2025 to file lead plaintiff applications in a securities class action lawsuit against Nutex Health Inc. (“Nutex” or the “Company”) (NasdaqCM: NUTX), if they purchased the Company’s securi...
Themefolio
Profiler
Peergroup
© BusinessWire
25.08.2025
ERF
LISTED
EURONEXT
Eurofins Scientific: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF T...
Themefolio
Profiler
Peergroup
© BusinessWire
25.08.2025
LIVN
LISTED
NASDAQ
LivaNova to Host Investor Day on November 12, 2025
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it will host an Investor Day and product showcase on Wed., Nov. 12, 2025, beginning at 9 a.m. EST until approximately 1 p.m. EST in New York City and via webcast. Members of the executive leadership team, including Chief Executive Officer Vladimir Makatsaria...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.08.2025
ORY
LISTED
BME
ORYZON Receives European Medicines Agency Approval to Initiate a Phase Ib Study of Iadademstat in Sickle Cell Disease
News Preview
MADRID and CAMBRIDGE, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, Ticker: ORY), a clinical-stage biopharmaceutical company and a European leader in epigenetics, today announced that the European Medicines Agency (EMA) has approved its Clinical Trial Application (CTA), the European equivalent to an IND,...
Themefolio
Profiler
Peergroup
© PR Newswire
25.08.2025
BIOA B
LISTED
STO
Leqembi® (lecanemab) launched in the EU today
News Preview
STOCKHOLM, Aug. 25, 2025 /PRNewswire/ --BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai announced today that the launch of Leqembi in the EU started in Austria on August 25, 2025, and will be launched in Germany on September 1, 2025. Leqembi received the European Commission (EC) approval in April 2025 as the first therapy that targ...
Themefolio
Profiler
Peergroup
© PR Newswire
25.08.2025
BIOA B
LISTED
STO
Leqembi® (lecanemab) launched in the EU today
News Preview
STOCKHOLM, Aug. 25, 2025 /PRNewswire/ --BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai announced today that the launch of Leqembi in the EU started in Austria on August 25, 2025, and will be launched in Germany on September 1, 2025. Leqembi received the European Commission (EC) approval in April 2025 as the first therapy that targ...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.08.2025
OSE
LISTED
EURONEXT
OSE Immunotherapeutics Proposes Governance Evolution and Reaffirms Strategic Priorities ahead of Annual General Meeting
News Preview
OSE Immunotherapeutics Proposes Governance Evolution and Reaffirms Strategic Priorities ahead of Annual General MeetingNew Board Structure Reflects Balanced and Proportionate Shareholder Representation New Governance to Drive Strategic Roadmaps for Tedopi® and Lusvertikimab...
Themefolio
Profiler
Peergroup
© BusinessWire
22.08.2025
TEM
LISTED
NASDAQ
Tempus Announces the Acquisition of Paige
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the acquisition of Paige, an AI company specializing in digital pathology. The acquisition allows Tempus to grow its dataset, expand its experienced technical team, and establish a strong footprint in digital pathology with...
Themefolio
Profiler
Peergroup
© EQS Newswire
22.08.2025
VLA
LISTED
EURONEXT
First Berlin Equity Research GmbH: Valneva SE | Rating: Buy
News Preview
Original-Research: Valneva SE - von First Berlin Equity Research GmbH
22.08.2025 / 15:14 CET/CEST
Veröffentlichung einer Research, übermittelt durch EQS News - ein Service der EQS Group.
Für den Inhalt der Mitteilung bzw. Research ist alleine der Herausgeber bzw. Ersteller der Studie verantwortlich. Diese Meldung ist keine Anlageberatung oder Au......
Themefolio
Profiler
Peergroup
© BusinessWire
22.08.2025
LIVN
LISTED
NASDAQ
LivaNova to Present at Baird and Morgan Stanley Global Healthcare Conferences in September
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that Vladimir Makatsaria, Chief Executive Officer, and Alex Shvartsburg, Chief Financial Officer, will present a general business update during fireside chats at the two following September healthcare conferences in New York City:
Baird 2025 Global Healthc...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.08.2025
NSIS B
LISTED
CPH
Trading by management and close relations of management
News Preview
Please read the announcement in PDF...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.08.2025
NSIS B
LISTED
CPH
Trading by management and close relations of management
News Preview
Please read the announcement in PDF...
Themefolio
Profiler
Peergroup
© PR Newswire
22.08.2025
SECT_B
LISTED
STO
Invitation to presentation of Sectra's three-month report 2025/2026
News Preview
LINKÖPING, Sweden, Aug. 22, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) invites investors, analysts, and the media to a presentation of the company's three-month report with President Torbjörn Kronander and CFO Jessica Holmquist.
Publication of the financial report: 8:15 a.m. (CEST) on Sep...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.08.2025
BAVA
LISTED
CPH
Bavarian Nordic Announces First Half 2025 Results
News Preview
COPENHAGEN, Denmark, August 22, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress for the first half of 2025 and released its financial calendar for 2026....
Themefolio
Profiler
Peergroup
© Globe Newswire
21.08.2025
NSIS B
LISTED
CPH
Novonesis delivered 9% organic sales growth in H1 and full-year outlook range narrowed to 6-8%
News Preview
COPENHAGEN, Denmark – August 21, 2025. Novonesis delivered 9% organic sales growth in H1 and full-year outlook range narrowed to 6-8%....
Themefolio
Profiler
Peergroup
© Globe Newswire
21.08.2025
NSIS B
LISTED
CPH
Interim report H1 2025
News Preview
9% organic sales growth in H1 and FY outlook range narrowed to 6-8%...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.08.2025
GN
LISTED
CPH
Interim Report Q2 2025: Commercial and operational agility drove market share gains and 46% EBITA growth
News Preview
Highlights...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.08.2025
ZEAL
LISTED
CPH
Zealand Pharma major shareholder announcement: Van Herk Investments B.V.
News Preview
Company announcement – No. 19 / 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
20.08.2025
INDV
LISTED
NASDAQ
Indivior to Participate in Upcoming Investor Events
News Preview
RICHMOND, Va., Aug. 20, 2025 /PRNewswire/ -- Indivior PLC (NASDAQ: INDV) today announced that it will participate in the following investor events:
Morgan Stanley 23rd Annual Global Healthcare Conference – New York City, NYJoe Ciaf...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.08.2025
NSIS B
LISTED
CPH
2030 financial targets announced: Organic sales growth acceleration, margin expansion and ROIC improvement
News Preview
COPENHAGEN, Denmark - August 20, 2025. Novonesis today announces its ‘GROW’ strategy and long-term targets for the strategy period until 2030 focusing on an acceleration of the core business and significant re-investments to secure long-term growth. By 2030, the company expects to deliver an organic sales CAGR of 6-9%, an adjusted EBITDA margin of...
Themefolio
Profiler
Peergroup
© BusinessWire
20.08.2025
MURA
LISTED
NASDAQ
MURA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Mural Oncology plc Is Fair to Shareholders
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Mural Oncology plc (NASDAQ: MURA) to XOMA Royalty Corporation for $2.035 per share and, up to an additional $0.205 per share under certain conditions, is fair to Mural shareholders.
Halper Sadeh encourages Mural shareholders to click here to learn more about thei...
Themefolio
Profiler
Peergroup
© EQS Newswire
20.08.2025
PHARM
LISTED
EURONEXT
First Berlin Equity Research GmbH: Pharming Group NV | Rating: Buy
News Preview
Original-Research: Pharming Group NV - from First Berlin Equity Research GmbH
20.08.2025 / 16:37 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude ......
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
